International Guillain-Barré Syndrome Outcome Study
What is the purpose of this trial?
International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS).
The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.
- N/A - N/A
- Erasmus Medical Center
- May 2012
- Last Updated:
- March 2, 2015
- Study HIC#:
Clinicaltrials.gov ID: NCT01582763